Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Immunovant Inc stock
Learn how to easily invest in Immunovant Inc stock.
Immunovant Inc is a biotechnology business based in the US. Immunovant Inc shares (IMVT) are listed on the NASDAQ and all prices are listed in US Dollars. Immunovant Inc employs 124 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Immunovant Inc
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – IMVT – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Immunovant Inc stock price (NASDAQ: IMVT)Use our graph to track the performance of IMVT stocks over time.
Immunovant Inc shares at a glance
|Latest market close||$4.88|
|52-week range||$3.15 - $9.54|
|50-day moving average||$4.93|
|200-day moving average||$5.45|
|Wall St. target price||$9.75|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.43|
Buy Immunovant Inc shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Immunovant Inc stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Immunovant Inc price performance over time
|1 week (2022-09-19)||0.62%|
|1 month (2022-08-26)||-17.71%|
|3 months (2022-06-24)||17.03%|
|6 months (2022-03-23)||-13.48%|
|1 year (2021-09-24)||-43.58%|
|2 years (2020-09-25)||-86.30%|
|3 years (2019-09-26)||10.02|
|5 years (2017-09-22)||N/A|
Immunovant Inc financials
|Gross profit TTM||$0|
|Return on assets TTM||-24.58%|
|Return on equity TTM||-41.55%|
|Market capitalisation||$533.9 million|
TTM: trailing 12 months
Immunovant Inc share dividends
We're not expecting Immunovant Inc to pay a dividend over the next 12 months.
Immunovant Inc share price volatility
Over the last 12 months, Immunovant Inc's shares have ranged in value from as little as $3.145 up to $9.535. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Immunovant Inc's is 0.8669. This would suggest that Immunovant Inc's shares are less volatile than average (for this exchange).
Immunovant Inc overview
Immunovant, Inc. , a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as completed initiation of Phase II clinical trials for the treatment of warm autoimmune hemolytic anemia. The company was incorporated in 2018 is headquartered in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd. .
Immunovant Inc in the news
Immunovant to Present at Roivant Investor Day on September 28th
Immunovant to Present at Roivant Investor Day on September 28th
Immunovant to Present at the H.C. Wainwright 24th Annual Global Investment Conference on September 14th
Frequently asked questionsWhat percentage of Immunovant Inc is owned by insiders or institutions?
Currently 64.783% of Immunovant Inc shares are held by insiders and 41.466% by institutions. How many people work for Immunovant Inc?
Latest data suggests 124 work at Immunovant Inc. When does the fiscal year end for Immunovant Inc?
Immunovant Inc's fiscal year ends in March. Where is Immunovant Inc based?
Immunovant Inc's address is: 320 West 37th Street, New York, NY, United States, 10018 What is Immunovant Inc's ISIN number?
Immunovant Inc's international securities identification number is: US45258J1025 What is Immunovant Inc's CUSIP number?
Immunovant Inc's Committee on Uniform Securities Identification Procedures number is: 42227C102
More guides on Finder
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
We’ve rounded up stats on some of the most popular wheat stocks, along with information on how these stocks compare and how to invest.
Ask an Expert